Filter
4870
Filtered Results: 4870
Text search:
Drug
research
Featured
Recommendations
398
New Publications
1275
Language
Document type
No document type
3028
Studies & Reports
791
Guidelines
556
Manuals
178
Strategic & Response Plan
141
Fact sheets
70
Training Material
50
Situation Updates
19
Infographics
13
Brochures
10
Resource Platforms
9
Online Courses
3
App
1
Videos
1
Countries / Regions
India
272
Global
156
Kenya
154
Western and Central Europe
111
Ethiopia
110
Uganda
108
South Africa
106
Nigeria
103
Nepal
90
Liberia
79
Malawi
79
Africa
78
Zambia
76
Sierra Leone
73
Tanzania
73
Myanmar / Burma
66
Latin America and the Carribbean
66
Ghana
65
Bangladesh
61
Ukraine
57
Eastern Europe
56
Rwanda
52
Philippines
43
Russia
43
Asia
40
Zimbabwe
39
Namibia
37
Cambodia
36
South–East Asia Region
33
Lesotho
32
Indonesia
30
Mozambique
24
Congo, Democratic Republic of
23
Brazil
23
Botswana
22
Senegal
21
Syria
20
Germany
18
East and Southern Africa
18
Burkina Faso
17
Eswatini/ Swaziland
17
South Sudan
16
Colombia
16
West and Central Africa
16
Middle East and North Africa
15
Tajikistan
15
USA
14
Cameroon
13
Haiti
12
Pakistan
11
Thailand
11
Eastern Europe and Central Asia
11
Albania
11
Sudan
10
Argentina
10
Georgia
10
Guinea
9
China
9
Vietnam
9
Afghanistan
8
Venezuela
8
North Macedonia
7
Armenia
7
Laos
7
Moldova
7
Benin
6
Iraq
5
Peru
5
Mexico
5
Sri Lanka
5
Yemen
5
Western Pacific Region
5
Jordan
4
Lebanon
4
Central African Republic
4
Angola
4
Southern Africa
4
United Kingdom
4
Guinea-Bissau
3
Somalia
3
Turkey
3
Papua New Guinea
3
Serbia
3
Libya
3
Chile
3
Paraguay
3
Bhutan
3
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
Jamaica
3
Belarus
3
Mali
2
Morocco
2
Saudi Arabia
2
Hungary
2
Ecuador
2
El Salvador
2
Poland
2
Palestine
2
Canada
2
Estonia
2
Kazakhstan
2
North America
2
Belgium
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Chad
1
Gambia
1
Ireland
1
Singapore
1
Honduras
1
Bolivia
1
Greece
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Romania
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1805
Clinical Guidelines
435
Public Health
246
Women & Child Health
182
Key Resources
85
Pharmacy & Technologies
64
Capacity Building
59
Annual Report MEDBOX
1
Toolboxes
HIV
578
Mental Health
565
TB
497
AMR
267
COVID-19
211
NTDs
180
Pharmacy
126
NCDs
103
Caregiver
81
Ebola
78
Planetary Health
76
Rapid Response
73
Disability
56
Refugee
54
Global Health Education
53
Conflict
45
Health Financing Toolbox
30
Polio
19
Natural Hazards
16
Zika
15
Specific Hazards
15
Social Ethics
12
Cholera
10
Health Financing
1
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates show that despite lackluster economic growth and fi...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
